Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2014.04.008PMID 24844605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia

  2013cited by this paper
• Naïve T-cells in Myelodysplastic Syndrome Display Intrinsic Human Telomerase Reverse Transcriptase (hTERT) Deficiency

  2012cited by this paper
• Telomere length in myelodysplastic syndromes

  2011cited by this paper
• Unraveling the molecular pathophysiology of myelodysplastic syndromes.

  2011cited by this paper
• Innate immune signaling in the myelodysplastic syndromes.

  2010cited by this paper
• Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells.

  2009cited by this paper
• Increase of telomerase activity and hTERT expression in myelodysplastic syndromes

  2009cited by this paper
• Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

  2008cited by this paper
• Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease

  2008cited by this paper
• Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.

  2008cited by this paper
• Myelodysplastic syndromes

  2007cited by this paper
• Telomerase activity in myelodysplastic syndromes.

  2005cited by this paper
• Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.

  2003cited by this paper
• Telomere measurement by quantitative PCR.

  2002cited by this paper
• SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity.

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Inhibition of telomerase limits the growth of human cancer cells

  1999cited by this paper
• Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos.

  1999cited by this paper
• Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

  1998cited by this paper
• Fas/APO-1 (CD95) expression in myelodysplastic syndromes.

  1998cited by this paper
• International scoring system for evaluating prognosis in myelodysplastic syndromes.

  1997cited by this paper
• Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)

  1997cited by this paper
• Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.

  1996cited by this paper
• Telomerase activity in normal leukocytes and in hematologic malignancies.

  1995cited by this paper
• The two-stage mechanism controlling cellular senescence and immortalization.

  1992cited by this paper

• Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

  2026cites this paper
• A Novel Guardian of Telomeres: RIOK2 Regulates Telomerase Activity Through TRiC and Dyskerin Complexes

  2025cites this paper
• Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients

  2025cites this paper
• Imetelstat: A new addition to the Therapeutic Landscape of Lower-Risk MDS.

  2024cites this paper
• The emerging role of MCPH1/BRIT1 in carcinogenesis

  2023cites this paper
• Epidemiology and Pathogenesis of Myelodysplastic Syndrome

  2023cites this paper
• Advances in myelodysplastic syndromes: promising novel agents and combination strategies

  2023cites this paper
• Raising the bar for lower-risk myelodysplastic syndromes

  2023cites this paper
• Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).

  2023cites this paper
• Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

  2021cites this paper
• Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes

  2021cites this paper
• Parsing the Paradox of Myelodysplastic Syndromes.

  2020cites this paper
• Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.

  2020cites this paper
• TERT—Regulation and Roles in Cancer Formation

  2020cites this paper
• Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia.

  2019cites this paper
• Significance of alternative splicing in cancer cells

  2019cites this paper
• Correlations between the expression of hTERT and α and β splice variants in human brain tumors.

  2019cites this paper
• Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.

  2018cites this paper
• Telomerase and telomere biology in hematological diseases: A new therapeutic target.

  2017cites this paper
• MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells

  2016cites this paper
• AZT-mediated inhibition of telomerase activity suppresses pancreatic cancer cell proliferation and enhances their radiosensitivity

  2016cites this paper
• Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

  2015cites this paper
• Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells

  2015cites this paper